These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 9384471

  • 1. Octreotide (SMS 201-995) for hematopoietic support-dependent high-dose chemotherapy (HSD-HDC)-related diarrhoea: dose finding study and evaluation of efficacy.
    Wasserman E, Hidalgo M, Hornedo J, Cortés-Funes H.
    Bone Marrow Transplant; 1997 Nov; 20(9):711-4. PubMed ID: 9384471
    [Abstract] [Full Text] [Related]

  • 2. A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer.
    Elias AD, Richardson P, Avigan D, Ibrahim J, Joyce R, Demetri G, Levine J, Warren D, Arthur T, Reich E, Wheele C, Frei E, Ayash L.
    Bone Marrow Transplant; 2001 Feb; 27(3):269-78. PubMed ID: 11277174
    [Abstract] [Full Text] [Related]

  • 3. A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.
    Hu WW, Long GD, Stockerl-Goldstein KE, Johnston LJ, Chao NJ, Negrin RS, Blume KG.
    Clin Cancer Res; 1999 Nov; 5(11):3411-8. PubMed ID: 10589752
    [Abstract] [Full Text] [Related]

  • 4. Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer.
    Klein JL, Rey PM, Dansey RD, Karanes C, Du W, Abella E, Cassells L, Hamm C, Peters WP, Baynes RD.
    Bone Marrow Transplant; 2000 May; 25(10):1047-52. PubMed ID: 10828864
    [Abstract] [Full Text] [Related]

  • 5. High-dose thiotepa and etoposide-based regimens with autologous hematopoietic support for high-risk or recurrent CNS tumors in children and adults.
    Papadopoulos KP, Garvin JH, Fetell M, Vahdat LT, Garrett TJ, Savage DG, Balmaceda C, Bruce J, Sisti M, Isaacson S, De LaPaz R, Hawks R, Bagiella E, Antman KH, Hesdorffer CS.
    Bone Marrow Transplant; 1998 Oct; 22(7):661-7. PubMed ID: 9818693
    [Abstract] [Full Text] [Related]

  • 6. High-dose chemotherapy with haematopoietic stem-cell support in patients with poor prognosis, relapsed or refractory germ cell tumours.
    El-Helw LM, Naik JD, Chester JD, Joffe JK, Selby PJ, Coleman RE.
    BJU Int; 2006 Sep; 98(3):519-25. PubMed ID: 16925746
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dose-intense paclitaxel, etoposide and cyclophosphamide: a safe and active regimen for tumor cytoreduction and stem cell mobilization in metastatic breast cancer.
    Bilgrami S, Feingold JM, Bona RD, Edwards RL, Khan AM, Rodriguez-Pinero F, Khan IA, Kazierad D, Clive J, Tutschka PJ.
    Bone Marrow Transplant; 2000 Jan; 25(2):123-30. PubMed ID: 10673668
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A phase II study of two cycles of high-dose chemotherapy with autologous stem cell support in patients with metastatic breast cancer who meet eligibility criteria for a single cycle.
    Bashey A, Corringham S, Garrett J, Lane TA, Gilpin EA, Corringham RE, Law P, Ho AD.
    Bone Marrow Transplant; 2000 Mar; 25(5):519-24. PubMed ID: 10713629
    [Abstract] [Full Text] [Related]

  • 12. Multimodality treatment including early high-dose chemotherapy with peripheral blood stem cell transplantation in limited-disease small cell lung cancer.
    Brugger W, Fetscher S, Hasse J, Frommhold H, Pressler K, Mertelsmann R, Engelhardt R, Kanz L.
    Semin Oncol; 1998 Feb; 25(1 Suppl 2):42-8. PubMed ID: 9535211
    [Abstract] [Full Text] [Related]

  • 13. A Phase I dose escalation trial of continuous infusion paclitaxel to augment high dose cyclophosphamide and thiotepa plus stem cell rescue for the treatment of patients with advanced breast carcinoma.
    Zimmerman TM, Grinblatt DL, Malloy R, Williams SF.
    Cancer; 1998 Oct 15; 83(8):1540-5. PubMed ID: 9781947
    [Abstract] [Full Text] [Related]

  • 14. Autologous platelet transfusion in patients receiving high-dose chemotherapy and circulating progenitor cell transplantation for stage II/III breast cancer.
    Pedrazzoli P, Perotti C, Noris P, Da Prada GA, Zibera C, Battaglia M, Gibelli N, Preti P, Pavesi L, Torretta L, Balduini CL, Salvaneschi L, Robustelli della Cuna G.
    Haematologica; 1998 Aug 15; 83(8):718-23. PubMed ID: 9793256
    [Abstract] [Full Text] [Related]

  • 15. Dose escalation of the hypoxic cell sensitizer etanidazole combined with ifosfamide, carboplatin, etoposide, and autologous hematopoietic stem cell support.
    Elias AD, Wheeler C, Ayash LJ, Schwartz G, Ibrahim J, Mills L, McCauley M, Coleman N, Warren D, Schnipper L, Antman KH, Teicher BA, Frei E.
    Clin Cancer Res; 1998 Jun 15; 4(6):1443-9. PubMed ID: 9626461
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A phase I-II study of high-dose melphalan, mitoxantrone and carboplatin with peripheral blood stem cell support in patients with advanced ovarian or breast carcinoma.
    Weaver CH, Greco FA, Hainsworth JD, Zhen B, Baldwin P, Wittlin F, Lewis M, West WH, Schwartzberg L, Buckner CD.
    Bone Marrow Transplant; 1997 Nov 15; 20(10):847-53. PubMed ID: 9404925
    [Abstract] [Full Text] [Related]

  • 18. A randomized trial of amifostine in patients with high-dose VIC chemotherapy plus autologous blood stem cell transplantation.
    Hartmann JT, von Vangerow A, Fels LM, Knop S, Stolte H, Kanz L, Bokemeyer C.
    Br J Cancer; 2001 Feb 02; 84(3):313-20. PubMed ID: 11161394
    [Abstract] [Full Text] [Related]

  • 19. Treatment-related mortality in 1000 consecutive patients receiving high-dose chemotherapy and peripheral blood progenitor cell transplantation in community cancer centers.
    Weaver CH, Schwartzberg LS, Hainsworth J, Greco FA, Li W, Buckner CD, West WH.
    Bone Marrow Transplant; 1997 Apr 02; 19(7):671-8. PubMed ID: 9156243
    [Abstract] [Full Text] [Related]

  • 20. Octreotide for the treatment of diarrhoea in patients with ileal pouch anal anastomosis: a placebo-controlled crossover study.
    Van Assche G, Ferrante M, Vermeire S, Noman M, Rans K, Van der Biest L, Penninckx F, Wolthuis A, Rutgeerts P, D'Hoore A.
    Colorectal Dis; 2012 Apr 02; 14(4):e181-6. PubMed ID: 21951549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.